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I. INTRODUCTION 
 
A. The key elements for an EU post-1999 drugs strategy were endorsed by the 
Cardiff European Council in June 1998, outlined in the report submitted to it (7930/2/98 
LIMITE Cordrogue 26/SAN 80/PESC 118/EUROPOL 70).  The Cardiff European 
Council also called for a comprehensive plan to be developed.  
 
Subsequently building on the European union drug strategy (1995–1999) (9012/99 
CORDROGUE 33), the Vienna European Council in December 1998 invited the 
institutions to develop further an integrated and balanced post-1999 drugs strategy taking 
into account the new possibilities offered by the Amsterdam Treaty. According to the 
European Council, full use should be made of the expertise of the European Monitoring 
Centre for Drugs and Drug Addiction, as well as Europol in this context.  
 
It is against this background and according to these orientations that the Commission has 
submitted the Communication from the Commission to the Council, the European 
Parliament, the Economic and Social Committee and the Committee of Regions on the 
European Union Action Plan to combat Drugs (2000-2004).   
 
The new drug strategy is now called for, since the existing EU drug strategy expires by 
the end of the year 1999. The treaty of Amsterdam has created numerous new 
possibilities which must be examined and utilised as well in the area of drug policy as a 
  
part of human health protection as in the area of police, customs and juridical co-
operation. 
 
The European Council special meeting held in October 1999 in Tampere underlined the 
importance of addressing the drugs problem in a comprehensive manner. It called on the 
Council to adopt the EU drug strategy 2 000–2004 before the European Council meeting  
in Helsinki.   
 
On the basis of the guidance of the European Council, the work of the previous 
presidencies, the Commission Communication as well as contributions from the Member 
States and council working groups to the Commission Communication, the Presidency 
puts forward this proposal for an EU drug strategy (2000-2004) with due consideration to 
the views of the Parliament as well as before mentioned institutions and bodies and 
involving them fully in the implementation phase of the strategy.  
 
B. The current drug situation as well as measures and achievements in drug-related 
action on the EU level as well as in Member States have been described in EMCDDA 
Annual report on the state of the drugs problem in the EU, and Europol's EU situation 
report on drug production and drug trafficking. 
 
While the most serious health problems are caused by the use of opiates (and in particular 
by heroin), amphetamines, cocaine and multiple-drug use, cannabis is still the most 
commonly used illicit drug.  
The new synthetic drugs as well as transmission of diseases through intravenous use of 
drugs require constant attention. Organised crime plays an increasingly dominant role in 
drug production and trafficking, necessitating enhanced customs, police and juridical co-
operation and particularly action against money laundering.  
 
Local and regional authorities as well as local communities play an important role in the 
planning and implementation of the EU drug strategy. 
 
 
II. THE NEW POSSIBILITIES PROVIDED  BY THE TREATY OF 
AMSTERDAM 
 
Article 152 of the EC treaty stipulates that a high level of human health protection shall 
be ensured in the definition and implementation of all Community policies and activities. 
A specific reference to drugs is made in the Article, stipulating that the Community shall 
complement the Member States' action in reducing drugs-related harm, including 
information and prevention.  
 
Title VI of the Treaty on European Union provides a new framework for co-operation in 
the field of Justice and Home Affairs. Article 29 describes the Union objectives being to 
provide citizens with a high level of safety within an area of freedom, security and 
justice. This objective must be achieved by preventing and combating crime. Illicit drug 
trafficking is mentioned in this context.  
  
 
According to the Article 31, common action on judicial co-operation in criminal matters 
shall include progressively adopting measures establishing minimum rules relating to the 
constituent elements of criminal acts and penalties in the fields of organised crime, 
terrorism and illicit drug trafficking.  
 
The Action Plan of the Council and the Commission on how best to implement the 
provisions of the Amsterdam treaty establishing an area of freedom, security and justice, 
adopted at the meeting of the European Council of December 1998 in Vienna (cf. 
document 13844/98 JAI 41), contains a timetable for law enforcement measures and 
judicial co-operation in criminal matters to be approved within two and five years after 
the Treaty's ratification. This lends itself to enhanced operational law enforcement  co-
operation. Improving co-operation between prosecuting and investigating authorities eg. 
by creating juridical authorities´ network, is a major goal.  
 
Implementation or the Customs Information System and Naples II Conventions will as 
well improve information exchange and law enforcement co-operation.   
 
The new possibilities created by the Amsterdam Treaty include: 
the requirement  to ensure human health protection in all community policies and actions, 
provision for wider, cross-sectoral activities in the field of drugs, 
an overall direction of public health actions towards improving public health, prevention of human illness 
and diseases, and obviating sources of danger to public health,  
the call for research into the causes and prevention of major health scourges, thus facilitating 
the full use of community research programmes, 
co-operation through initiatives aiming at exchanges of experience and best practise in order to combat 
social exclusion,  
support for co-operation at EU level between police, customs and other law enforcement 
services of the Member States,   
enabling Europol within a period of five years after the date of entry into force of the treaty of Amsterdam 
to facilitate and support the preparations and encourage the coordination between Member 
States,  
promoting new investigation techniques, co-operation between Member States´ law enforcement agencies,  
and research and documentation of drug-related crime, 
contributing to reinforcing the Justice and Home Affairs Acquis, which is of particular 
importance to the enlargement process,  
considering conditions under which law enforcement authorities and juridical authorities may operate in an 
other state in liaison and agreement with the authorities of that state, in particular according to the 
Schengen convention, 
Facilitating and accelerating juridical cooperation in criminal matters. 
 
The aims laid down in the Amsterdam treaty were reinforced by the Tampere European 
Council. It called for joint investigative teams to be set up to combat cross-border crime 
and concrete steps to be  taken against money laundering, including approximation of 
criminal laws and procedures on money laundering. 
 
III. THE PRINCIPLES AND OBJECTIVES OF THE EU DRUG STRATEGY 
(2000–2004) 
  
 
In line with the principle of subsidiarity the general aims of the EU Drug Strategy 2000–
2004 are the following: 
to ensure that the issue of drugs is kept as a major priority for EU internal and external action, 
to ensure that actions against drugs are evaluated, 
to continue the EU global, multidisciplinary, integrated and balanced strategy, in which supply and demand 
reduction are seen as mutually reinforcing elements, as underlined by the United Nations General 
Assembly Special Session on Drugs (UNGASS) 
to give greater priority to drug prevention and demand reduction, particularly new recruitment to drug use, 
as well as the  reduction of the adverse consequences of drug use, 
to reinforce the fight against organised crime, illicit drug trafficking and related organised crime as 
well as other drug-related crime, and to step up police, customs and judicial co-operation 
between Member States, 
to encourage multi-agency co-operation and the involvement of civil society,  
to fully utilise the new possibilities offered by the Treaty of Amsterdam, particularly the 
articles on health protection and drug control, police co-operation and judicial co-
operation as well as the common minimum standards in legislation. Article 31(e) foresees 
the  progressive adoption of measures establishing minimum rules relating to the 
constituent elements of criminal acts and penalties in the fields of organised crime, 
terrorism and illicit drug trafficking, 
To ensure collection, analysis and dissemination of objective, reliable and comparable data on the drugs 
phenomenon in the EU with the support of EMCDDA and Europol, 
to progressively integrate the candidate countries and to intensify international cooperation with other 
countries and international organisations,  
To promote international co-operation, integration of drug control into EU development co-operation and 
to support the efforts of the United Nations and of UNDCP in particular to develop international co-
operation, based on the principles adopted at the UNGASS in June 1998, 
To emphasise that the successful implementation of the strategy and actions mentioned in this Strategy will 
necessitate appropriate resources.  
 
The main targets for the EU drug strategy are  
to reduce significantly over five years the prevalence of illicit drug use, as well as new recruitment to it, 
particularly among young people under 18 years of age, 
to reduce substantially over five years the incidence of drug-related health damage (HIV, hepatitis B 
and C, TBC, etc.) and the number of drug-related deaths,  
to increase substantially the number of successfully treated addicts, 
to reduce substantially over five years the availability of illicit drugs, 
to reduce substantially over five years the number of drug related crime, 
to reduce substantially over five years money-laundering and illicit trafficking of precursors. 
 
 
IV. THE MAIN CHARACTERISTICS OF THE EU APPROACH  
 
The European approach is balanced, multidisciplinary and integrated. In the spirit of the 
texts adopted in 1998 UNGASS Declaration on the guiding principles of drug demand 
reduction by and its corresponding Action Plan, it is aimed at:  
a) reducing the demand of drugs, through the prevention, particularly among the 
young, treatment and rehabilitation and the reduction of its adverse consequences,   
  
b) preventing drug supply through law enforcement action, with particular attention 
to police, customs and juridical co-operation and fight against drug-related organised 
crime and money laundering, 
c) reducing illicit cultivation by actions such as the promotion of alternative 
development. 
d) promoting international co-operation. 
These  measures shall complement and reinforce each other.  
 
Co-operation between Member States in drugs policies should be encouraged, including 
exchange of information between the responsible authorities. 
 
The problems linked to drug abuse are to be seen in context of broader social 
disadvantage such as poverty, deprivation, unemployment, homelessness and social 
exclusion. Improved social well-being, in particular support for families and those in 
most difficult circumstances, will be an effective shield against drug problems.  
 
Tackling the drugs problem is a priority for co-operation in the fields of public well-
being, health and education, Justice and Home affairs as well as in relations with non- 
member countries and relevant international fora. This reflects the horizontal nature of 
the problem.  
 
Prevention of drug abuse and supply  should  therefore involve representatives of  all 
appropriate authorities as well as the civil society. The various actors in the prevention 
field should develop a close co-operation. This requires a strong policy of multi-agency 
action and common agreements on strategies, measures and targets and consciousness of 
mutual benefits of such co-operation. Social and health sectors as well as educators and 
law enforcement agencies should work in close partnership in order to ensure appropriate 
services to drug offenders as well as in other areas of prevention. 
 
The role of citizens, including risk groups themselves,  is of paramount importance in 
drug-related action. Non-governmental organisations have a long tradition in raising 
public awareness and educating the young as well as helping drug addicts and their 
families, and coping with the damage caused. They are often in a pioneering position in 
developing visions and methods for our work. Citizen participation is also necessary to 
ensure the transparency of  the EU strategy, since the development of drugs policy 
presupposes a special concern for open, frank and critical discussion.  The European drug 
strategy will be devised and carried out in close co-operation with the civil society. 
International non-governmental networks and activities of cities, facing the drug problem, 
will be supported.   
 
International co-operation is based on the principles of shared responsibility and 
partnership and carried out in adherence to the international conventions. The drug 
problem is viewed in the context of a broad set of human welfare issues addressing the 
social and economic dimensions of sustainable development.    
 
V. ACTION ON DEMAND REDUCTION 
  
 
A. Approach to demand reduction 
 
Building on previous experience, gained from ie. implementation and mid-term 
evaluation of the first programme of Community action in the prevention of drug 
dependence, the European Union continues its action on drug demand reduction. 
 
The Treaty of Amsterdam provides for wide, cross-sectional activities in the field of 
drugs. According to  Article 152 the Community shall complement the Member States' 
action in reducing drugs-related harm, including information and prevention. 
 
Declaration on the guiding principles of drug demand reduction adopted at the UNGASS 
covers all areas of prevention, from discouraging the initial use to reducing the negative 
health and social consequences of drug abuse. These Guiding principles and the Action 
Plan on Demand reduction need to be fully implemented by all Member States.  
 
Work also needs to be undertaken with regard to driving under the influence of illicit 
drugs and medicines; in particular further scientific review of the link between drugs and 
road accidents to enable Member States to develop evidence based strategies to address 
this problem and to promote the exchange of experiences in the approach to this problem.  
 
Inclusion of addiction prevention strategies and treatment of illnesses caused by use of 
legal and illegal drugs should be an integral part of community health policies. 
 
It is necessary to develop and implement preventive actions and strategies for all age 
groups, particularly children and young people. Such actions should, instead of focusing 
exclusively on illegal drugs, rather address risk behaviour and addiction in general, 
including aspects of alcohol, medicine, substances used for doping in sports and tobacco 
use.  
 
Children need to be made aware of the risks involved with the use of drugs, alcohol and 
tobacco just  before they are confronted with these substances. Children and young 
people need both knowledge and skills to make responsible choices about their 
behaviour. Efforts directed at young people as well as other target groups should involve 
their own contributions to ensure peer influences and support.  
 
Children and young people need to be provided positive alternatives and  leisure time 
activities. Parents, educators and other adults must realise the strong influence they 
necessarily exercise through their own behaviour and attitudes. An early detection of 
children's and young persons' risk behaviour and possibly underlying problems, together 
with appropriate action to support them and their families, before any drug misuse has 
taken place, is an effective method of prevention. Programmes for parents, especially in 
areas where there is high prevalence of drug misuse, are also beneficial. 
 
  
The general public should be informed on the effects of the social exclusion, particularly 
from the viewpoint of drugs problem. Media campaigns should be designed to support 
local and practical action. 
 
Prevention should be seen as a broad cross-administrative issue involving all operators in 
society, and further co-operation and devising of common strategies and projects between 
different authorities should be encouraged as well as research-based design of demand 
reduction strategies and activities. Training of professionals from social, health, 
education, law enforcement and sports sectors is a prerequisite for effective action.  
  
Multi-drug use, often accompanied with alcohol and other substances, should be handled 
more successfully as well as drug use related to mental health problems. There is an 
increasing number of ageing drug users who need specific attention in reducing drugs-
related health damage.  
 
Preventive measures should be developed for drug use in prisons and alternative 
measures to imprisonment as well as facilities for addicted prisoners should be further 
implemented. 
 
Exchange of information should be encouraged on measures to counter the adverse health 
and social consequences of  drug use. Such measures may include low threshold-services, 
if  Member States find it appropriate, and  measures to counteract the exclusion of drug 
addicts from social life. Exchange of information should also take place in the field of 
treatment, concerning experiences and best practices in i.e. drug substitution 
programmes. 
 
 
B. Specific topics 
 
To reduce the use and ill effects of new synthetic drugs,  particularly following action is 
needed: research on the risks of new synthetic drugs and  patterns of use, the prevention 
of abuse and the reduction of harmful consequences, and dissemination of relevant 
information to the public. 
 
The new information technologies such as the Internet provide a powerful means for 
exchange of views and information. It is also a possibility when it comes to addressing 
young people and involving them directly in prevention activities, of which member 
States already have good experiences.  The use of the Internet for the provision of 
objective,  reliable and educational information-giving on drugs and the harmful effects 
of drug use should be promoted and facilitated.  
 
 
VI. ACTION ON SUPPLY REDUCTION 
 
A. Approach to drug-related organised crime 
 
  
Effective combating of international organised drug trafficking requires increased and 
improved law enforcement and judicial co-operation between Member States and with 
third countries.  
 
The international nature of organised drug trafficking calls for a dynamic, co-ordinated 
response by all Member States,  a response that not only takes into account national 
strategies, but also seeks to become an integrated, multidisciplinary European Union 
strategy. Such a strategy requires action at different levels.  
  
 
At the strategic level a reliable assessment is needed on the role of individual organised 
crime groups and the extent to which the different geographic levels in the European 
Union correlate and, for instance, drug trafficking functions as a whole. This requires 
operational and empirical data on the profile, motives and modus operandi of offenders, 
the dynamics of illicit markets, trafficking routes, the scope of, and trends in, organised 
crime and its impact on society. The assessment should be carried out and updated 
periodically, preferably by Europol, with the involvement of the academic and scientific 
world.  
 
Furthermore, research is needed into the effectiveness of combating organised drug-
related crime, including drug trafficking. Crime and policy indicators should be 
developed to assess progress in the control and the prevention of organised crime. Here, 
too, scientists should play a role. 
 
An integrated and  multidisciplinary European union strategy is also needed to ensure 
that limited resources in the Member States are deployed in order to achieve maximum 
results in the combating of international organised crime.  
 
From a law enforcement perspective, the strategy should be made operational through the 
implementation of the project-based European Union law enforcement strategy against 
transnational organised crime, as laid down in the document Crimorg 167.  This strategy 
takes into account the methods of co-operation in the field of Justice and Home Affairs, 
as foreseen in the Treaty of Amsterdam:  Closer co-operation between Police forces, 
Customs and other competent authorities, directly or through Europol; closer co-
operation between judicial and other competent authorities and approximation, when 
necessary, of the rules on criminal matters in the Member States.  
 
In this respect, the European Judicial Network has established contact points in each 
Member State, which are available to judicial authorities to assist requests for judicial co-
operation. In the future, the network may be linked to Europol. The creation of EuroJust 
decided by the European Council in Tampere should also be an important instrument for 
facilitating the cooperation and coordination of juridical authorities. 
 
The integration of the Schengen aquis in the field of drugs will constitute an important 
element, taking into account the operational activities and measures undertaken in the 
Schengen framework. In this respect, consideration will be given to the arrangements 
  
under which law enforcement officers from one Member State can operate in the territory 
of another, as is foreseen under the Schengen Treaty.  
 
The conclusions of the Tampere European Council give a strong foundation for the 
practical development of  drug-related police, customs and juridical co-operation. Full 
integration of Schengen aquis will underline the importance of the effective control of the 
Union´s future external borders.  
 
B. Specific topics 
 
B.1. Money laundering 
 
According to the conclusions of  the Tampere European Council, money laundering is at 
the very heart of organised crime. The European Council adopted a number of measures 
to intensify action against it to ensure that concrete steps are taken to trace, freeze, seize 
and confiscate the proceeds of crime.  
 
The member States continue to take an active position against money laundering and seek 
to ensure that the financial sector meets its responsibilities set out in  the Council 
directive of 1991. In order to approximate legislation, as far as the money laundering 
offences and provisions on confiscation are concerned, and to enhance co-operation in 
this respect, a joint action was adopted in December 1998.  
 
Participation in the FATF and  Council of Europe and Octopus Programme on control of 
organised crime and corruption shows the willingness of the EU to be a major player in  
co-ordinated  international activity in this field. The conclusions 51–58 of the Tampere 
European Council show that a new impetus is given to action against money laundering.  
 
Efforts to curb money laundering will be intensified by: 
rapid adoption and subsequent implementation of the recently proposed amendments to the money 
laundering directive to update and extend the scope of the 1991 Directive,  
helping non-EU countries and regions develop their anti-money-laundering systems and strengthening 
control of money laundering through EU's support for technical assistance projects in this area and 
in close co-operation with Financial Action Task Force and the UN efforts,  
giving efforts against money laundering a priority in current and coming  assistance and co-operation 
programs, notably TACIS and Phare, 
developing a system for analysing and exchanging information between Financial 
Intelligence units of the Member States. Regardless of secrecy provisions applicable to 
banking and other commercial activity, juridical authorities as well as FIUs should 
become entitled, subject to juridical control, to receive information when such 
information is necessary to investigate money laundering,  
extending the competence of Europol , as requested by the European Council of Tampere, to money 
laundering in general, regardless of the type of offence from which the laundered proceeds 
originate. 
 
B.2 The control of chemical precursors 
 
  
Precursors are an important area of the supply reduction side of the drugs problem as they 
are indispensable in the production of drugs. Many of these chemicals are widely traded 
and commonly used in legitimate pharmaceutical and industrial processes but a small part 
of this vast trade is diverted to the manufacture of illicit drugs. The basis in international 
law for controls of precursor chemicals is Article 12 of the 1988 UN Convention against 
Illicit Traffic in Narcotic Drugs and Psychotropic Substances to which the European 
Community is a party. Within the Community Council Regulation EEC 3677/90 (as 
amended) and Council Directive 92/109/EEC (as amended) give effect to the provisions 
of the Convention by setting up systems for control of the trade through licensing, 
registration and export authorisation. 
 
In addition to the 22 chemicals currently controlled there is a growing number of non-
scheduled precursors which are being used in illicit manufacture, particularly of synthetic 
drugs. It is not practical, nor would it be effective, to subject this growing and ever 
changing number of chemicals to strict formal controls and so new flexible systems are 
being sought. The establishment of voluntary monitoring mechanism for the new 
chemicals and  enhanced co-operation with the trade is being pursued through stronger 
community approach and the production of guidelines to raise awareness of the new 
chemicals and to assist industry in the identification and notification of suspicious 
transactions.  
 
Bilateral agreements on precursor control with third countries ensure a continuing 
dialogue and better co-operation and information exchange to combat diversion. 
Discussions on appropriate mechanisms for improving precursor control continue with 
the associate countries. 
 
 
B.3 New  Synthetic drugs 
 
The emergence of new synthetic drugs has made it necessary to find ways to respond 
quickly to appearance of new substances and consumption trends. The enhancement of 
this capacity together with developing more efficient information gathering and 
management will constitute the major challenges in this area.  
 
So far the Joint Action of June 1997 in which Europol and EMCDDA have  a specific 
role and which created the Early Warning system for new synthetic drugs, has been a 
promising and effective tool in coping with this challenge, and such mechanisms should 
be reinforced.   
 
Further  measures to enhance the effectiveness of action against the illicit trafficking of 
new synthetic drugs are needed, especially as regards 
the assessment and possible improvement of the joint action,  
co-operation against production and trafficking, including improved co-operation 
between national authorities and the industry, 
international co-operation with a particular emphasis on the candidate countries.  
 
  
B.4 Development co-operation and alternative development 
 
In the context of shared responsibility the EU sees an important contribution to world 
wide drug control policies in an international co-operation aiming at social and economic 
development in developing countries, mainly those involved in growing of illicit crops 
(poppy, coca and cannabis). Development co-operation should assist population groups 
that are giving up illegal crops to create alternative sources of income. Particularly 
important in this context are programmes of alternative development in countries 
producing illicit drug plants in co-ordination with UNDCP when appropriate. 
 
B.5 Use of new communication systems 
 
While not wanting to limit legitimate use of the Internet, including free exchange of 
opinions on drugs and drug policies, attempts to use it  for drug-related illicit purposes 
must be countered. These include particularly illicit marketing of drugs as well as 
information, material and equipment for promotion of  illicit manufacture of drugs. The 
control authorities' efforts against illicit drugs trade via the Internet should be intensified.  
 
 
VII. ACTION AT INTERNATIONAL LEVEL 
 
The global nature of the drug problem calls for intensified international co-operation. In 
particular its destabilising influence to local economies, particularly corruption, should 
not be underestimated. The common threat that illicit drugs pose to all countries requires 
drug-related action to be kept high on the international agenda; this includes prevention 
of the use of drugs and reducing their harmful effects as well as tackling  the illicit 
cultivation, production, processing and trafficking of drugs and their  precursors. Other 
related organised crime, such as money laundering, also needs to be addressed.  
 
Through the adoption of the Political Declaration at the UNGASS, the international 
community subscribed to the principles of shared responsibility and balanced approach, 
committing itself to reducing both the demand and supply of illicit drugs. 
In the EU, international co-operation to tackle the drugs problem is seen as part of  the 
Union's overall efforts to foster social and economic development; drug control efforts 
need to be integrated into mainstream development. Ownership of projects by partner 
countries, sustainability of projects and respect for human rights must be an underlying 
principle in all co-operation. 
 
Whereas the Vienna European Council of December 1998 declared Latin 
America/Caribbean as well as Central Asia as priority regions, EU co-operation in the 
field of drugs should also be targeted on the associated countries, on other countries in 
Central and Eastern Europe (including Balkan countries), South and West Asia, SADC 
countries and other parts of Africa, particularly North and West Africa. Co-operation 
with developed countries needs to be enhanced both bilaterally and within multilateral 
fora. 
 
  
The EU will intensify its efforts at the international level by: 
implementing the various action plans and sets of measures adopted at the UNGASS, co-operating with the 
United Nations International Drug Control Programme (UNDCP). 
intensifying its co-operation with international and regional organisations, in particular with 
the World Health Organisation and other United Nations organisations as well as with the 
Council of Europe. 
integrating its efforts to tackle the drugs problem into the broader objectives of EU external relations, 
including development co-operation, in different multilateral and regional settings as well 
as through bilateral action. 
making full use of the instruments of common foreign and security policy, including political dialogue, 
common positions and joint actions, common strategies as well as of trade policy 
instruments and technical and financial assistance. 
intensifying  co-operation with third countries in the fields of demand and supply reduction as well as 
justice and home affairs;  the combined efforts of all relevant authorities will be needed here, 
with a particular role for Europol. 
Designing a drugs strategy with specific objectives, which is in line with the integration process of the 
associated countries of Central and Eastern Europe. 
 
 
VIII. INFORMATION AND EVALUATION 
 
The EU drug strategy  has to be based on a regular assessment of the nature and 
magnitude of drugs phenomenon and its consequences as well as on knowledge acquired 
from research and lessons derived from past programmes.  The present strategy itself 
must also be evaluated.  
 
The regular assessment produced by the European Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA) and by Europol constitute valuable resources for the identification 
of any emerging trends and the improvement of the knowledge at EU level on the drugs 
phenomenon. The EMCDDA must develop an even closer relationship with the member 
countries through the National Focal Points.  
 
It is the task EMCDDA to collect, analyse, compare and report existing data on the drugs 
phenomenon. It is of the utmost importance to ensure that the highest quality of 
information flows to and from  it.  
 
Actions: 
Improving comparability of data is a central task of the EMCDDA. The national focal points will  play a 
central role in this context.  
Progressive harmonisation of key epidemiological indicators on the prevalence and health consequences of 
drug use is needed.  
National authorities should reinforce their commitment to this challenge with political and institutional 
support. 
Systematic and scientific evaluation of demand and supply reduction activities should be developed.  
appropriate assessment of Community legislation and its implementation in the field of control in trade of 
precursors 
 
 
  
In the past Member States and the Commission have given insufficient priority to 
evaluation of anti-drugs activity. This must change and evaluation must be an integral 
part of the EU approach. Programs should be evaluated wherever possible by 
independent experts.  The results of these evaluations should be taken into account when 
designing new programs.  In this field the EMCDDA has issued and will continue to 
issue guidelines for the evaluation of demand and supply reduction activities and models 
for the assessment of policies. 
 
 
_____________ 
